 recombinant human erythropoietin-blood letting strategy anemia iron overload hemodialysis patients feasibility refractory anemia post-transfusional serious hemochromatosis patient hemodialysis weekly fourteen years recombinant human erythropoietin r-HuEPO blood-letting Blood transfusion patient rate units packed red cells month years r-HuEPO U/kg b.w i.v end hemodialysis Hct ml blood hemodialysis session attempt iron loss Excellent control anemia hemochromatosis months treatment patient general condition skin pigmentation